Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.
about
Platinum versus non-platinum chemotherapy regimens for small cell lung cancerTwenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing resultsSmall cell lung cancer: therapies and targetsThe role of anthracyclines in small cell lung cancer.Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501).Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive casesManagement of small cell lung cancer: recent developments for optimal care.Cisplatin plus etoposide versus other platin-based regimens for patients with extensive small-cell lung cancer: a systematic review and meta-analysis of randomised, controlled trials.Medical treatment of small cell lung cancer: state of the art and new development.A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung CancerDosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.Identification of new candidate drugs for lung cancer using chemical-chemical interactions, chemical-protein interactions and a K-means clustering algorithm.Current standards for clinical management of small cell lung cancer.
P2860
Q24188039-F9555161-BC66-42A5-9AC4-8544C8A7ADDBQ30886032-1ED6D8D6-3C0C-4705-B5DA-0A80A457105FQ34250859-E0075009-D4A4-46E1-825F-092CDC876356Q34358063-647878CD-2A0C-4535-8928-FF9E90C4A05FQ34977383-76BB8B77-565D-431B-8A75-18CDFF4219F5Q35595219-DC4472AE-8CFF-4132-9996-C3E2B7FCCC2BQ37987205-A09DC651-799B-4784-B411-C2D3771DCBA8Q38005201-EC6785D2-D43E-4270-A413-37241130CE2CQ38125489-267746F0-AB6F-4389-8A60-671A00D0FFE6Q41860470-A0F2EB4A-DB35-4E51-8DA2-3B3DB49FC054Q44257627-93E90006-7965-46A6-BE97-1CAB7D97BBAFQ44476097-811F30F0-0524-418A-9EDC-7E0AA5E57523Q47133539-D685D637-7890-4948-A807-0F59D58E9267Q50718626-0A3D860F-E9AC-4A6E-9D5F-38F23334CBC2Q54953051-7A6822F4-9FB0-4667-93BF-8FF6E523D598
P2860
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Phase III randomised trial of ...... apy in small-cell lung cancer.
@en
type
label
Phase III randomised trial of ...... apy in small-cell lung cancer.
@en
prefLabel
Phase III randomised trial of ...... apy in small-cell lung cancer.
@en
P2093
P2860
P50
P356
P1476
Phase III randomised trial of ...... apy in small-cell lung cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604480
P407
P577
2008-08-01T00:00:00Z